






















lARTICLE IN PRESSBRE-290; No. of Pages 8





econdary  hyperalgesia  occurs  regardless  of
nilateral or bilateral  knee osteoarthritis
nvolvement in individuals  with  mild  or  moderate
evel
anessa Martins Pereira Silva Moreiraa,∗, Saulo Delﬁno Barbozaa,
uliana  Borges Oliveirab, Janser Moura Pereirac, Valdeci Carlos Dionisioa
Master Program in Health Sciences, Faculty of Medicine, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
Faculty of Physical Education, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
Faculty of Mathematics, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 12 October 2015







a  b  s  t  r  a  c  t
Background: Secondary hyperalgesia in individuals with less severe levels of knee
osteoarthritis remains unclear. The objective of this study was to measure the pressure
pain threshold of individuals with mild or moderate knee osteoarthritis and compare with
no  osteoarthritis.
Methods: Ten healthy controls and 30 individuals with mild or moderate knee osteoarthritis
divided into two groups (unilateral and bilateral involvement) were included. Dermatomes
in  lumbar levels (L1, L2, L3, L4 and L5) and sacral level (S1 and S2), myotomes (vastus medi-
alis,  vastus lateralis, rectus femoris, adductor longus, tibialis anterior, peroneus longus,
iliacus, quadratus lumborum, and popliteus muscles), and sclerotomes in lumbar levels
(L1-L2, L2-L3, L3-L4, L4-L5 supraspinous ligaments), over the L5-S1 and S1-S2 sacral areas,
pes anserinus bursae, and at the patellar tendon pressure pain threshold were assessed and
compared between individuals with and without knee osteoarthritis.
Results: Knee osteoarthritis groups (unilateral and bilateral) reported lower pressure pain
threshold compared to the control group in most areas (dermatomes, myotomes, and scle-
rotomes). There were no between group differences in the supra-spinous ligaments and over
the L5-S1 and S1-S2 sacral areas of the sclerotomes. No difference was seen between knee
osteoarthritis.
Conclusion: These ﬁndings suggest that individuals with mild to moderate knee osteoarthri-
tis had primary and secondary hyperalgesia, independent of unilateral or bilateral
involvement. These results suggest that the pain have to be an assertive focus in the clinicalPlease cite this article in press as: Pereira Silva Moreira VM, et al. Secondary hyperalgesia occurs regardless of unilateral or bilateral knee
osteoarthritis involvement in individuals with mild or moderate level. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
practice, independent of the level of severity or involvement of knee osteoarthritis.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A  hiperalgesia  secundária  ocorre  independentemente  do  envolvimento
unilateral  ou  bilateral  da  osteoartrite  de  joelho  em  indivíduos  com  doenc¸a




Limiar de dor à pressão
Hiperalgesia secundária
r  e  s  u  m  o
Introduc¸ão: A ocorrência de hiperalgesia secundária em indivíduos com níveis menos graves
de  osteoartrite de joelho ainda é incerta. O objetivo deste estudo foi medir o limiar de
dor  à pressão de indivíduos com osteoartrite de joelho leve ou moderada e comparar com
indivíduos sem osteoartrite.
Métodos: Foram incluídos 10 controles saudáveis e 30 indivíduos com osteoartrite de joelho
leve ou moderada, divididos em dois grupos (envolvimento unilateral e bilateral). Foi avali-
ado  e comparado o limiar de dor à pressão em dermátomos nos níveis lombares (L1, L2,
L3,  L4, L5) e níveis sacrais (S1 e S2), miótomos (músculos vasto medial, vasto lateral, reto
femoral, adutor longo, tibial anterior, ﬁbular longo, ilíaco, quadrado do lombo e poplíteo)
e  esclerótomos nos níveis lombares (ligamentos supraespinais L1-L2, L2-L3, L3-L4, L4-L5),
sobre as áreas sacrais L5-S1 e S1-S2, bolsa anserina e tendão patelar entre os indivíduos
com e sem osteoartrite de joelho.
Resultados: Os grupos osteoartrite de joelho (unilateral e bilateral) relataram menor limiar
de  dor à pressão em comparac¸ão com o grupo controle na maior parte das áreas (dermá-
tomos, miótomos e esclerótomos). Não houve diferenc¸as entre os grupos nos ligamentos
supraespinais e ao longo das áreas sacrais L5-S1 e S1-S2 dos esclerótomos. Não foi observada
qualquer diferenc¸a entre os indivíduos com osteoartrite de joelho.
Conclusão: Esses achados sugerem que os indivíduos com osteoartrite de joelho leve a mod-
erada tinham hiperalgesia primária e secundária, independentemente do acometimento
unilateral ou bilateral. Esses resultados sugerem que a dor precisa serum foco assertivo na
prática clínica, independentemente do grau de gravidade ou envolvimento da osteoartrite
de  joelho.
© 2016 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CCIntroduction
The knee is the most common joint affected by osteoarthri-
tis, and the prevalence increases with aging.1 Pain is the
main symptom of knee osteoarthritis (KOA), and its presence
and severity are important determinants of decreased func-
tional capacity.2,3 Primary hyperalgesia has been deﬁned as
increased activity of primary afferent nociceptors at the site
of a determined injured tissue, while secondary hyperalgesia
is deﬁned as presence of pain in areas beyond the original
injured area.4 Primary and secondary hyperalgesia may occur
in KOA and result in modulation of nociceptors and spinal
horn neurons, respectively.5
The pressure pain threshold (PPT) has been considered
the most reliable parameter to classify inﬂammation in
osteoarthritis,6,7 and has been used to detect the presence
of secondary hyperalgesia in dermatomes, myotomes, and
sclerotomes.2,5 PPT seems to have different levels between
individuals with and without osteoarthritis,2,8 however, cur-
rent evidence does not answer if PPT levels are different
between the different severities (e.g., mild or moderate) of
KOA.2,9,10 In the past, Gerecz-Simon et al.11 evaluated individ-
uals with knee OA, but just pain was mild and moderate. Also,
they used only two points in lower limb. Recently, it has beenPlease cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
demonstrated that individuals with moderate KOA present
localized pain and not contralateral hyperalgesia,12 however,
in this study, although not mentioned, the characteristicsBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
of the participants suggests that individuals had unilateral
KOA. Therefore, assessing PPT in multiples points might bring
meaningful information about the pain, as well as contribute
to clinical approach. As joint damage occurs gradually in
osteoarthritis (i.e., with progressive function loss of tissue
stabilizers),13 secondary hyperalgesia would be expected to
occur in the development process of osteoarthritis, and uni-
lateral or bilateral involvement might play a role on this,14
resulting in different painful points. Thus, this study aimed
to measure the PPT levels in mild or moderate KOA individ-
uals with unilateral and bilateral involvement and compare to
individuals without KOA. We  hypothesized that some level of
secondary hyperalgesia would be present in individuals with
mild and moderate KOA and would be effect of unilateral or
bilateral involvement.
Materials  and  methods
Participants
After the University Research Ethics Committee approval (No.
0012/2010) and conforms the Helsinki Declaration of 1975, the
study recruitment was carried out in the Rheumatology Clinic
of the university hospital and TV regional news. Four hundred-dary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
thirty individuals with KOA were contacted via telephone.
Sixty individuals attended the personal evaluation to conﬁrm
their adjustment in the criteria for inclusion/exclusion.
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Table 1 – Characteristics of knee osteoarthritis (KOA) and healthy control individuals.
Individuals Age
(mean ± SD)
Gender I/MI knee Severity KOA Medications
Control
(n = 10)
57.8  ± 6.22 Females
(n = 6)
–  – –
Males
(n = 4)









(n  = 7)






(n  = 8)
Bilateral
(n = 15)





(n  = 4)
n  = 7







































SD, standard deviation; I, involved knee in unilateral KOA; MI, more i
For inclusion, individuals should be 50-years-old or more,
ave diagnosed KOA in the evaluation (unilateral or bilat-
ral), and pain for at least 6 months. The diagnosis of KOA
as based on the classiﬁcation of the American College of
heumatology,15 accompanied by radiological evidence of
steoarthritis affecting one or more  compartments, according
o the radiological criteria of Kellgren and Lawrence.16 Indi-
iduals were excluded if they had any of the following: other
usculoskeletal disorders; chronic diffuse pain (ﬁbromyalgia),
hronic inﬂammatory conditions, such as autoimmune dis-
ases (rheumatoid arthritis, lupus, gout); diabetes mellitus;
euromuscular disorders, such as Parkinson’s disease; vertigo
r other conditions that could affect the sensory capabilities
nd control of movement. Individuals who  used central con-
rol of pain medications, such as antidepressants also were
xcluded, but individuals who used oral nonsteroidal anti-
nﬂammatory drugs, it was allowed to continue its use.
After selection, 30 individuals with KOA were included. Ten
ndividuals older than 50 years who had no history of injury,
urgery, and pain in the lower extremities were selected by
onvenience to compose the control group. All included par-
icipants signed the informed participation consent, and were
ivided into three groups: bilateral KOA (n = 15), unilateral KOA
n = 15) and control (n = 10). Table 1 shows the participants’
haracteristics.
ain  assessment
 digital force gauge (Force TENTM FDX, Wagner Instruments,
reenwich, CT, USA) and with a ﬂat ½ inch diameter head
ere used for mechanical quantiﬁcation of hyperalgesia and
llodynia resulting from peripheral or central nociceptive sen-
itization. The measurements were performed bilaterally in
he dermatomes at levels L1, L2, L3, L4, L5, S1 and S2, using
he pinch and roll maneuver described by Imamura et al.5
he same was taken for myotomes, at nine predetermined
ocations (vastus medialis, vastus lateralis, rectus femoris,Please cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
dductor longus, tibialis anterior, peroneus longus, iliacus,
uadratus lumborum, and popliteus muscles). Finally, the
clerotomes were evaluated in the L1–L2, L2–L3, L3–L4, L4–L5
upraspinous ligaments, over the L5–S1 and S1–S2 sacral(n = 6) (n  = 11)
ed knee in bilateral KOA.
areas, pes anserinus bursae, and at the patellar tendon (Fig. 1).
Two experienced researchers collected all the data, using strict
criteria for the location of the points. The PPT was expressed
in kg/cm2, with the highest values denoting less severe symp-
toms.
Statistical  analysis
In many  situations it is necessary to check whether there is a
signiﬁcant difference in mean treatment k (k > 2). One solution
would be the F test through the analysis of variance (ANOVA),
which allows us to jointly test the means of k treatments. How-
ever, in some situations the model assumptions (normality
and homogeneity independence of residuals) are not satisﬁed.
Therefore we recommend the use of non-parametric tests,
i.e., a non-parametric inference. In this work we applied the
Kruskal–Wallis test consisting of a non-parametric ANOVA
because the assumptions of parametric ANOVA were not
met.17
Results
Signiﬁcant difference in the mean values of the PPT was
found between control and KOA unilateral and bilateral groups
(p < 0.03), while no difference was found between KOA uni-
lateral and bilateral groups. The KOA groups had a lower
pain threshold in most areas of the dermatomes (Table 2),
myotomes (Table 3), and sclerotomes (only the pes anserinus
bursae and patellar tendon; Table 4). However, there was no
difference in the mean values of the PPT (p > 0.05) in the scle-
rotomes of the supraspinous ligaments, over the L5-S1 and
S1-S2 sacral areas (Table 4).
Discussion
The aim of this study was to measure the PPT of individualsdary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
with mild and moderate KOA (with unilateral and bilateral
involvement) and compare with those without KOA.  The
results showed that compared to controls, individuals with
mild and moderate KOA had lower PPTs in most areas, while
ARTICLE IN PRESSRBRE-290; No. of Pages 8
















Fig. 1 – The anatomic sites used in the evaluation of the pressure pain threshold (PPT) of the muscles, patellar tendon, and
pes anserinus busae in the anterior, posterior, and lateral views. (1) Vastus medialis muscle; (2) rectus femoris muscle; (3)
vastus lateralis muscle; (4) adductor longus muscle; (5) anterior tibialis muscle; (6) peroneus longus muscle; (7) patellar
iac m
 adatendon; (8) pes anserinus bursae; (9) popliteal muscle; (10) il
ligaments and sacral areas between L5-S1 and S1-S2. Figure
no difference occurred between unilateral or bilateral KOA
involvement.
According Courtney et al.,18 primary hyperalgesia seems to
be based on sensitization of peripheral C-ﬁber nociceptors of
deep somatic tissues when a stimulus is applied at the location
of the inﬂammation. This process progresses if the nocicep-
tive stimulation persists. In such cases, the nerve endings of
the central nervous system may be altered because of the
increase in the receptive ﬁeld, making them more  sensitive
to stimuli.5 The increase in synaptic excitability increases the
response to both noxious and non-noxious stimuli, leading
to allodynia and secondary hyperalgesia. In secondary hyper-
algesia, a stimulus out of the lesion area causes pain in the
individual.18
Although the process of degeneration in KOA is not clear,Please cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
the results of this study revealed that the individuals with
mild to moderate KOA had primary and secondary hyper-
algesia, whereas the healthy controls did not. Comparing the
data from this study with those of Imamura et al.,5 it isuscle; (11) quadratus lumborum muscle; (12) supraspinous
pted from Imamura et al.5
suggested that when KOA progresses, secondary hyperalgesia
also increases. Imamura et al.5 also reported the presence of
secondary hyperalgesia in distant regions of the knee, includ-
ing the lumbar region, in severe KOA individuals. In contrast,
in the present study, the individuals with mild to moderate
KOA showed no alterations in the lumbar region. However,
there were changes in the pain threshold of distant parts of the
knee that exhibited secondary hyperalgesia (Tables 2 and 3).
Therefore, our results suggest the secondary hyperalgesia
would occur along the degeneration process and would not be
a feature present only in the severe level of KOA.  Similar results
were showed by Rakel et al.,12 however, the PPT points were
only in one point each primary and secondary hyperalgesia,
and the way to determinate of the mild KOA was considered a
limitation of the study by authors. The present study used the
15dary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
classiﬁcation of the American College of Rheumatology, and
therefore, it conﬁrms the results of Rakel et al.,12 adding the
sensitivity to mechanical stimulus in dermatomes, myotomes,
and sclerotomes.
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Table 2 – Results Kruskal–Wallis test for pressure pain threshold on dermatomes.
Dermatomal 2a p-Value Groups Mean of the ranksb,c
L1 18.7044 0.0022
Control
Right  knee 61.55 a
Left knee 57.85 a
Unilateral
Involved knee 34.97 b
Noninvolved knee 34.97 b
Bilateral
More involved knee 35.00 b
Less involved knee 31.40 b
L2 13.9418 0.0159
Control
Right  knee 58.05 a
Left knee 55.70 a
Unilateral
Involved knee 31.97 b
Noninvolved knee 34.33 b
Bilateral
More involved knee 35.20 b
Less involved knee 38.67 b
L3 23.2273 0.0003
Control
Right  knee 61.70 a
Left knee 62.20 a
Unilateral
Involved knee 33.87 b
Noninvolved knee 34.23 b
Bilateral
More involved knee 35.47 b
Less involved knee 29.83 b
L4 22.0370 0.0005
Control
Right  knee 62.15 a
Left knee 59.8 a
Unilateral
Involved knee 31.67 b
Noninvolved knee 39.20 b
Bilateral
More involved knee 30.30 b
Less involved knee 33.53 b
L5 19.7702 0.0014
Control
Right  knee 59.60 a
Left knee 61.15 a
Unilateral
Involved knee 32.10 b
Noninvolved knee 35.70 b
Bilateral
More involved knee 34.83 b
Less involved knee 32.87 b
S1 22.3136 0.0005
Control
Right  knee 60.60 a
Left knee 61.50 a
Unilateral
Involved knee 33.63 b
Noninvolved knee 35.90 b
Bilateral
More involved knee 27.77 b
Less involved knee 37.30 b
S2 14.9281 0.0107
Control
Right  knee 58.45 a
Left knee 57.25 a
Unilateral
Involved knee 33.73 b
Noninvolved knee 34.73 b
Bilateral
More involved knee 34.73 b















g statistical value with one-tailed probability ˛.
b The mean ranks derive the means of PPT collected and was repres
c Different lowercase letters in the column, the means of the ranks o
Hassan et al.3 noted that drugs could act on peripheral
nd/or central pain mechanisms. However, in the present
tudy, part of the participants (n = 15; Table 1) were using, but
his seems to not interfere in PPT, since most of the PPT points
ere more  sensitive compared with control group. These
esults reinforce the evidence that drugs usually have limited
ction in chronic pain, and unsatisfactory in pain relief.19 Tay-
or et al.20 reported that both physicians and patients (51%
f respondents) are unhappy with the inadequate control of
OA provided by traditional anti-inﬂammatory non-steroidalPlease cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
herapy. Their study included patients with mild (31%) and
oderate or severe KOA (60%). In addition, these results sug-
est that for secondary hyperalgesia treatment and control of by lowercase letters.
 PPT differ by Kruskal–Wallis test at 5% signiﬁcance level.
pain in KOA, central pain drugs could be useful, since NSAIDs
act only on peripheral pain mechanisms.21
Riddle and Stratford14 found pain inﬂuence about the
side of involvement (unilateral or bilateral) measured by self-
report, but our results showed that pain not inﬂuenced the
side of involvement and not supported the results of the Rid-
dle and Stratford.14 Despite of important difference of size
sample between these studies, we should considerate that an
objective mechanism of pain mensuration (PPT) could be dif-
ferent of the self-report measure. Riddle and Stratford14 alsodary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
suggested that difference observed in function between uni-
lateral and bilateral pain could be a reﬂection of differences in
pain severity. The pain measured by self-report was associated
Please cite this article in press as: Pereira Silva Moreira VM, et al. Secondary hyperalgesia occurs regardless of unilateral or bilateral knee
osteoarthritis involvement in individuals with mild or moderate level. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
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Table 3 – Results Kruskal–Wallis test for pressure pain threshold on myotomes.
Myotomal 2a p-Value Groups Mean of the ranksb,c
ILIO 12.1881 0.0323
Control
Right  knee 55.10 a
Left knee 56.20 a
Unilateral
Involved knee 38.37 b
Noninvolved knee 31.00 b
Bilateral
More involved knee 35.63 b
Less involved knee 36.80 b
AL 17.8989 0.0031
Control
Right knee 62.95 a
Left knee 55.10 a
Unilateral
Involved knee 32.90 b
Noninvolved knee 32.47 b
Bilateral
More involved knee 34.83 b
Less involved knee 37.10 b
RF 24.3074 0.0002
Control
Right  knee 64.00 a
Left knee 61.10 a
Unilateral
Involved knee 32.83 b
Noninvolved knee 31.00 b
Bilateral
More involved knee 34.53 b
Less involved knee 34.23 b
VM 21.1307 0.0008
Control
Right  knee 59.15 a
Left knee 62.55 a
Unilateral
Involved knee 31.03 b
Noninvolved knee 34.03 b
Bilateral
More involved knee 37.17 b
Less involved knee 32.63 b
VL 18.8512 0.0020
Control
Right  knee 62.30 a
Left knee 57.10 a
Unilateral
Involved knee 35.33 b
Noninvolved knee 31.20 b
Bilateral
More involved knee 33.73 b
Less involved knee 36.13 b
TA 24.7054 0.0002
Control
Right  knee 61.20 a
Left knee 64.20 a
Unilateral
Involved knee 34.87 b
Noninvolved knee 34.37 b
Bilateral
More involved knee 32.17 b
Less involved knee 31.00 b
FL 21.5347 0.0006
Control
Right  knee 63.10 a
Left knee 59.10 a
Unilateral
Involved knee 30.30 b
Noninvolved knee 34.17 b
Bilateral
More involved knee 34.87 b
Less involved knee 35.20 b
QL 24.6522 0.0002
Control
Right  knee 59.35 a
Left knee 65.70 a
Unilateral
Involved knee 31.47 b
Noninvolved knee 33.10 b
Bilateral
More involved knee 32.17 b
Less involved knee 35.90 b
POP 26.3413 <0.000
Control
Right knee 62.35 a
Left knee 64.45 a
Unilateral
Involved knee 31.20 b
Noninvolved knee 34.70 b
Bilateral
More involved knee 30.77 b
Less involved knee 34.80 b
ILIO, iliacus muscle; AL, adductor longus muscle; RF, rectus femoris muscle; VM, vastus medialis muscle; VL, vastus lateralis muscle; TA, tibialis
anterior muscle; FL, peroneus longus muscle; QL, quadratus lumborum muscle; POP, popliteus muscle.
a 2 statistical value with one-tailed probability ˛.
b The mean ranks derive the means of PPT collected and was represented by lowercase letters.
c Different lowercase letters in the column, the means of the ranks of the PPT differ by Kruskal–Wallis test at 5% signiﬁcance level.
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Table 4 – Results Kruskal–Wallis test for pressure pain threshold on sclerotomes.
Sclerotomal 2a p-Value Groups Mean of the ranksb,c
TP 24.5637 0.0002
Control
Right knee 63.60 a
Left knee 61.30 a
Unilateral
Involved knee 34.43 b
Noninvolved knee 33.53 b
Bilateral
More involved knee 29.00 b
Less involved knee 35.77 b
PG 19.6622 0.0014
Control
Right knee 59.80 a
Left knee 59.95 a
Unilateral
Involved knee 33.67 b
Noninvolved knee 39.33 b
Bilateral
More involved knee 31.77 b
Less involved knee 31.40 b
L1-L2 3.9834 0.1364
Control
Right knee 48.00 a
Left knee 43.20 a
Unilateral
Involved knee 43.27 a
Noninvolved knee 39.83 a
Bilateral
More involved knee 41.63 a
Less involved knee 30.47 a
L2-L3 2.3155 0.3142
Control
Right knee 37.22 a
Left knee –
Unilateral
Involved knee 37.58 a
Noninvolved knee –
Bilateral
More involved knee 45.60 a
Less involved knee –
L3-L4 4.4425 0.1085
Control
Right knee 37.62 a
Left knee –
Unilateral
Involved knee 47.48 a
Noninvolved knee –
Bilateral
More involved knee 35.43 a
Less involved knee –
L4-L5 1.5373 0.4636
Control
Right knee 40.30 a
Left knee –
Unilateral
Involved knee 36.85 a
Noninvolved knee –
Bilateral
More involved knee 44.28 a
Less involved knee –
L5-S1 3.3315 0.1890
Control
Right knee 47.45 a
Left knee –
Unilateral
Involved knee 41.10 a
Noninvolved knee –
Bilateral
More involved knee 35.27 a
Less involved knee –
S1-S2 0.3497 0.8396
Control
Right knee 39.30 a
Left knee –
Unilateral
Involved knee 39.32 a
Noninvolved knee –
Bilateral
More involved knee 42.48 a
Less involved knee –
PT, patella tendon; PG, pes anserinus bursae; L1-L2, L1-L2 supraspinous ligament; L2-L3, L2-L3 supraspinous ligament; L3-L4, L3-L4 supraspinous
ligament; L4-L5, L4-L5 supraspinous ligament; L5-S1, L5-S1 sacral area; S1-S2, S1-S2 sacral area.






wb The mean ranks derive the means of PPT collected and was repres
c Different lowercase letters in the column, the means of the ranks o
ith psychological state according to Wise et al.,22 which could
14Please cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
ave inﬂuenced the results of Riddle and Stratford.
Finally, in this study two researchers made the collection
f the data and we did not assess the inter-rater reliability,
hat can be considered a limitation of the study, since there by lowercase letters.
 PPT differ by Kruskal–Wallis test at 5% signiﬁcance level.
could be a slight difference in the locations of the anatomical
points. However, they were both experienced and used strictdary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
criteria for the location of the points. As reported by Fisher,6
the individual described by the PPT is well correlated between
different researchers and local analysis.
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28  r e v b r a s r e u m a t o
Taking all together, individuals with mild to moderate KOA
had primary and secondary hyperalgesia, independent of uni-
lateral or bilateral involvement. These results suggest that the
pain have to be an assertive focus in the clinical practice, inde-
pendent of the level of severity or involvement of KOA.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
Acknowledgments
We  appreciate the contribution of all students of the Labora-
tory of Physical Therapy and Neuromechanical of the Faculty
of Physical Education, Universidade Federal de Uberlândia, for
assistance in technical and discussions about it.
We thank the Fundac¸ão de Amparo a Pesquisa do Estado
de Minas Gerais (FAPEMIG) for their support of research (Grant
APQ-01110-10) and the Conselho Nacional de Desenvolvi-
mento Cientíﬁco e Tecnológico (CNPq) for scholarship to this
research.
 e  f  e  r  e  n  c  e  s
1. Shakoor N, Furmanov S, Nelson DE, Li Y, Block JA. Pain and its
relationship with muscle strength and proprioception in knee
OA: results of an 8-week home exercise pilot study. J
Musculoskelet Neuronal Interact. 2008;8:35–42.
2. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine
P,  Simonsen OH, et al. Sensitization in patients with painful
knee osteoarthritis. Pain. 2010;149:573–81.
3. Hassan BS, Doherty SA, Mockett S, Doherty M. Effect of pain
reduction on postural sway, proprioception, and quadriceps
strength in subjects with knee osteoarthritis. Ann Rheum Dis.
2002;61:422–8.
4. Hunter DJ, McDougall JJ, Keefe FJ. The symptoms of
osteoarthritis and the genesis of pain. Med Clin North Am.
2009;93:83–100.
5. Imamura M, Imamura ST, Kaziyama HHS, Targino RA, Hsing
WT,  de Souza LPM, et al. Impact of nervous system
hyperalgesia on pain, disability, and quality of life in patients
with knee osteoarthritis: a controlled analysis. Arthritis
Rheum. 2008;59:1424–31.
6. Fischer AA. Pressure algometry over normal muscles.Please cite this article in press as: Pereira Silva Moreira VM, et al. Secon
osteoarthritis involvement in individuals with mild or moderate level. Rev
Standard values, validity and reproducibility of pressure
threshold. Pain. 1987;30:115–26.
7. Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B,
Wylde  V, et al. Quantitative sensory testing in painful
2 1 6;x  x x(x x):xxx–xxx
osteoarthritis: a systematic review and meta-analysis.
Osteoarthritis Cartilage. 2012;20:1075–85.
8. Lee YC, Lu B, Bathon JM, Haythornthwaite JA, Smith MT,  Page
GG,  et al. Pain sensitivity and pain reactivity in osteoarthritis.
Arthritis Care Res. 2011;63:320–7.
9. Graven-Nielsen T, Wodehouse T, Langford RM,
Arendt-Nielsen L, Kidd BL. Normalization of widespread
hyperesthesia and facilitated spatial summation of
deep-tissue pain in knee osteoarthritis patients after knee
replacement. Arthritis Rheum. 2012;64:2907–16.
0. Stubhaug A, Breivik H. Knee osteoarthritis patients with
intact pain modulating systems may have low risk of
persistent pain after knee joint replacement. Scand J Pain.
2015;6:41–2.
1. Gerecz-Simon EM, Tunks ER, Heale J-A, Kean WF, Buchanan
WW.  Measurement of pain threshold in patients with
rheumatoid arthritis, osteoarthritis, ankylosing spondylitis,
and healthy controls. Clin Rheumatol. 1989;8:467–74.
2. Rakel B, Vance C, Zimmerman MB, Petsas-Blodgett N,
Amendola A, Sluka KA. Mechanical hyperalgesia and reduced
quality of life occur in people with mild knee osteoarthritis
pain. Clin J Pain. 2015;31:315–22.
3. Heijink A, Gomoll AH, Madry H, Drobnic M, Filardo G,
Espregueira-Mendes J, et al. Biomechanical considerations in
the  pathogenesis of osteoarthritis of the knee. Knee Surg
Sports Traumatol Arthrosc. 2012;20:423–35.
4. Riddle DL, Stratford PW. Unilateral vs bilateral symptomatic
knee osteoarthritis: associations between pain intensity and
function. Rheumatology. 2013;52:2229–37.
5. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K,
et  al. Development of criteria for the classiﬁcation and
reporting of osteoarthritis: classiﬁcation of osteoarthritis of
the knee. Arthritis Rheum. 1986;29:1039–49.
6. Kellgren JH, Lawrence JS. Radiological assessment of
osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.
7. Conover WJ.  Practical nonparametric statistics. 3rd ed. New
York: Wiley; 1999.
8. Courtney CA, Kavchak AE, Lowry CD, O’Hearn MA.
Interpreting joint pain: quantitative sensory testing in
musculoskeletal management. J Orthop Sports Phys Ther.
2010;40:818–25.
9. Ambrose KR, Golightly YM. Physical exercise as
non-pharmacological treatment of chronic pain: why and
when. Best Pract Res Clin Rheumatol. 2015;29:120–30.
0. Taylor SD, Everett SV, Taylor TN, Watson DJ, Taylor-Stokes G. A
measure of treatment response: patient and physician
satisfaction with traditional NSAIDs for osteoarthritis control.
Open Access Rheumatol Res Rev. 2013:69–76.
1. Batlouni M. Anti-inﬂamatórios não esteroides: efeitos
cardiovasculares, cérebro-vasculares e renais. Arq Brasdary hyperalgesia occurs regardless of unilateral or bilateral knee
 Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.03.014
Cardiol. 2010;94:556–63.
2. Wise BL, Niu J, Zhang Y, Wang N, Jordan JM, Choy E, et al.
Psychological factors and their relation to osteoarthritis pain.
Osteoarthritis Cartilage. 2010;18:883–7.
